Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Physiol.

Sec. Vascular Physiology

Volume 16 - 2025 | doi: 10.3389/fphys.2025.1648727

Minoxidil and Nebivolol Restore Aortic Elastic Fiber Homeostasis in Diabetic Mice via Potassium Channel Activation

Provisionally accepted
Auberi  HenryAuberi Henry1Laetitia  VanalderwiertLaetitia Vanalderwiert1Floriane  OszustFloriane Oszust1Amandine  WahartAmandine Wahart1Daniel  A Carvajal BerrioDaniel A Carvajal Berrio2Eva  BrauchleEva Brauchle2Katja  Schenke-LaylandKatja Schenke-Layland2Juergen  BrinckmannJuergen Brinckmann3Heiko  SteenbockHeiko Steenbock3Laurent  DebelleLaurent Debelle1Isabelle  SixIsabelle Six4Gilles  FauryGilles Faury5Stéphane  JaissonStéphane Jaisson1,6Philippe  GilleryPhilippe Gillery1,6Vincent  DurlarchVincent Durlarch1,6HERVE  SARTELETHERVE SARTELET1Pascal  MAURICEPascal MAURICE1Amar  BennasrouneAmar Bennasroune1Laurent  MARTINYLaurent MARTINY1Laurent  DUCALaurent DUCA1Beatrice  Romier-CrouzetBeatrice Romier-Crouzet1Sebastien  BlaiseSebastien Blaise1*
  • 1Université de Reims Champagne-Ardenne, Reims, France
  • 2Eberhard Karls Universitat Tubingen, Tübingen, Germany
  • 3Universitat zu Lubeck, Lübeck, Germany
  • 4Universite de Picardie Jules Verne, Amiens, France
  • 5Universite Grenoble Alpes, Saint-Martin-d'Hères, France
  • 6Centre Hospitalier Universitaire de Reims, Reims, France

The final, formatted version of the article will be published soon.

Background: Diabetic patients experience a significant reduction in life expectancy, primarily due to early cardiovascular complications. A key feature is the premature degradation of elastic fibers (EFs), contributing to vascular stiffness. Objective: This study evaluates the capacity of two antihypertensive agents, minoxidil (a KATP channel opener) and nebivolol (a β-blocker with KATP activity), to restore EF homeostasis and arterial elasticity in diabetic mice. Methods: Mice are treated with two antihypertensive agents: minoxidil (an ATP-sensitive potassium (KATP) channel opener) or nebivolol (a β-blocker also active on KATP channels). The degree of wear and functionality of EF are assessed after these treatments. We complement this analysis by identifying molecular actors from smooth muscle cell cultures. Results: Our data show that by applying these antihypertensive agents in cultured vascular smooth muscle cells in vitro and in diabetic mice, we efficiently stimulate elastogenesis and inhibit elastolysis. Therefore, treatments restore functional EFs and limit their degradation. This brings blood pressure values of diseased mice close to normal ones (as in unaffected mice). Elastogenesis pathway stimulation and elastolysis inhibition are induced by the opening of sensitive KATP channels and the regulation of the forkhead box transcription factor (FOXO1). Conclusion: Minoxidil and nebivolol restore EF integrity and limit vascular aging in diabetic mice via K+ channel opening and FOXO1 repression. These findings highlight potassium channel–FOXO1 signaling as a therapeutic axis to counteract diabetic vascular complications.

Keywords: Elastogenesis, Elastolysis, Aging, diabetes, FoxO1, potassium channel

Received: 17 Jun 2025; Accepted: 19 Aug 2025.

Copyright: © 2025 Henry, Vanalderwiert, Oszust, Wahart, Carvajal Berrio, Brauchle, Schenke-Layland, Brinckmann, Steenbock, Debelle, Six, Faury, Jaisson, Gillery, Durlarch, SARTELET, MAURICE, Bennasroune, MARTINY, DUCA, Romier-Crouzet and Blaise. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Sebastien Blaise, Université de Reims Champagne-Ardenne, Reims, France

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.